Comparing ultrasound and MRI for estimating fetal weight in large babies
Comparison of the Accuracy of Fetal Weight Estimation Between Sonographic Vs. Magnetic Resonance Assessment
This study is testing whether ultrasound or MRI is better at estimating the weight of large babies before birth for pregnant women who might have macrosomia.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | Female |
| Sponsor | Western Galilee Hospital-Nahariya Government |
| Locations | 1 site (Nahariya) |
| Trial ID | NCT06898892 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the accuracy of ultrasound versus magnetic resonance imaging (MRI) in estimating fetal weight for pregnancies suspected of macrosomia. Pregnant women at term with suspected macrosomia will undergo both ultrasound and MRI fetal weight assessments, with the actual birth weight recorded for comparison. The study will ensure that both the radiologist and sonographer are blinded to the estimations to maintain objectivity. The findings could help determine the most reliable method for fetal weight estimation in this specific population.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women at term with singleton pregnancies suspected of having macrosomia.
Not a fit: Patients with fetal anomalies, multiple gestations, or preterm premature rupture of membranes (PPROM) may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of fetal weight estimations, leading to better management of pregnancies at risk for macrosomia.
How similar studies have performed: While there have been studies on fetal weight estimation methods, this specific comparison of ultrasound and MRI in suspected macrosomia is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: singleton pregnancy at term, suspected fetal macrosomia, Exclusion Criteria: * fetal anomaly multiple pregnancy PROM
Where this trial is running
Nahariya
- Galilee medical center — Nahariya, Israel (Recruiting)
Study contacts
- Principal investigator: Amal shahin — Galilee Medical Center
- Study coordinator: Maya Frank Wolf, Prof.
- Email: mayaw@gmc.gov.il
- Phone: 972-50-7887800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.